Initiator Pharma
5 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase 2 Study to Evaluate the Efficacy and Safety of Pudafensine in Vulvodynia (Provoked Vestibulodynia) (NCT07391241) | Initiator Pharma | 2025-12-17 |
| Bioavailability Study to Compare Liquid vs Two Solid Formulations of IP2015 (NCT05728671) | Initiator Pharma | 2023-02-16 |
| Study to Investigate the Pharmacodynamic Effects of IP2015 in Healthy Male Subjects Using the Intradermal Capsaicin Model (NCT05181852) | Initiator Pharma | 2022-01-05 |
| A Phase II, Repeat Single Oral Dose Study of IPED2015 in Healthy Male Subjects With Erectile Dysfunction (NCT04969666) | Initiator Pharma | 2021-08-04 |
| Clinical Trial Studying the Efficacy and Safety of IP2018 in Depressed, Erectile Dysfunction (ED) Patients (NCT04686916) | Initiator Pharma | 2020-12-30 |
Track Initiator Pharma automatically
Every clearance here is in the API, with alerts when new ones post.